Trulieve Cannabis Corp. TRLV
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -9.10% | -3.90% | -1.39% | -0.45% | 1.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.10% | -3.90% | -1.39% | -0.45% | 1.44% |
| Cost of Revenue | -8.72% | 0.62% | 2.32% | -0.15% | -4.81% |
| Gross Profit | -9.34% | -6.76% | -3.75% | -0.65% | 5.92% |
| SG&A Expenses | -11.75% | -17.94% | -18.30% | -12.78% | 6.25% |
| Depreciation & Amortization | -12.22% | -1.22% | 3.19% | 4.26% | 4.93% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.47% | -8.45% | -7.45% | -5.59% | 0.95% |
| Operating Income | 2.16% | 55.49% | 79.33% | 60.33% | 5.64% |
| Income Before Tax | -534.02% | -1,073.29% | 209.78% | 114.06% | 17.37% |
| Income Tax Expenses | -43.22% | -28.38% | -8.79% | 5.33% | 6.32% |
| Earnings from Continuing Operations | -237.64% | -179.13% | 50.35% | 24.66% | -0.88% |
| Earnings from Discontinued Operations | 95.32% | -16.89% | 15.82% | 2.39% | -187.68% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -85.53% | -56.94% | 11.10% | 7.26% | 37.44% |
| Net Income | -234.36% | -184.01% | 50.81% | 24.96% | -3.51% |
| EBIT | 2.16% | 55.49% | 79.33% | 60.33% | 5.64% |
| EBITDA | -4.19% | 18.31% | 28.39% | 24.25% | 4.46% |
| EPS Basic | -255.03% | -193.10% | 51.09% | 25.47% | 10.22% |
| Normalized Basic EPS | -466.08% | -873.16% | 198.99% | 130.66% | 20.04% |
| EPS Diluted | -255.06% | -193.10% | 51.09% | 25.47% | 10.22% |
| Normalized Diluted EPS | -467.28% | -873.16% | 198.99% | 130.66% | 20.04% |
| Average Basic Shares Outstanding | 0.82% | 0.75% | 0.67% | 0.70% | 0.61% |
| Average Diluted Shares Outstanding | 1.83% | 0.75% | 0.67% | 0.70% | 0.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |